STAT Plus: As first lab-made yeast genome nears completion, scientists set sights on improved human ones
NEW YORK — For a project born in a cauldron of controversy three years ago,…
Author: STAT
Opinion: The U.S. needs extra action to eliminate viral hepatitis, the nation’s deadliest infectious disease
I traveled to Boston last weekend for the annual meeting of the American Association for…
Opinion: Adult vaccination saves lives. Why do so few adults get vaccinated?
Vaccines are among the simplest, most effective, and least expensive ways to prevent serious, and…
In a ‘Wild West’ environment, hospitals differ sharply in what patient data they give Google
In deals struck across the U.S., hospital systems appear to be adopting starkly different protocols…
A drug maker courted controversy when it shut out a family-run rival. Now some patients say the medicine isn’t working
Last February, Barbara Moore switched to a new medicine to combat a rare neuromuscular disease…
Listen: Google’s data grab, problematic genetic testing, & the perils of biotech Twitter
Do you trust Google with your health data? Is “Gattaca” an outdated reference? And what’s…
FDA slams Dollar Tree for purchasing drugs from suppliers with checkered safety records
Amid growing concerns over the pharmaceutical supply chain, regulators sternly warned the Dollar Tree (DLTR),…
Apple launches virtual health studies aiming to enroll hundreds of thousands of customers
SAN FRANCISCO — Apple on Thursday launched three observational studies — focused on mobility, menstruation,…
Opinion: Working with ICER, or around it, on cost-effectiveness estimates
As the national debate over prescription drug pricing reaches a fever pitch, drug manufacturers bringing…
Opinion: The FDA must pull Makena off the market
Should doctors be able to prescribe and use a drug that doesn’t work, and may…
In France, it’s illegal for consumers to order a DNA spit kit. Activists are fighting over lifting the ban
PARIS — From scanning her resume, you’d never guess Nathalie Jovanovic-Floricourt was an expert enabler…
STAT Plus: An FDA advisory panel is reviewing Amarin’s fish oil drug. Follow along for frequent updates
We’re monitoring Thursday’s meeting of the Food and Drug Administration advisory committee that is reviewing…
More trial results are being posted to public database, but data quality is lacking, report finds
A new report examining the first decade of study results being reported on ClinicalTrials.gov finds…
STAT Plus: After backlash, Teva will resume supplies of a critical children’s cancer medicine
In an about-face, Teva Pharmaceutical is resuming supplies of a critical cancer medicine for children…
HHS to probe whether Google’s ‘Project Nightingale’ followed federal privacy law
A federal regulator is investigating whether the federal privacy law known as HIPAA was followed…
Opinion: My daughter is gone but her legacy lives on through her writing and phage therapy
“Who lives, who dies, who tells your story?” That line from the musical “Hamilton” inspires…
Opinion: Abundant research shows gender disparities in medicine, but too few know about it. #NeedHerScience
Medicine has an abundance of highly trained and qualified women. So why are there so…
Opinion: STAT Plus: Microbiome drug development: a rapidly evolving field
Ground-breaking research on the microbiome — the collection of bacteria, fungi, and other microbes that…
Valued for their tech, Silicon Valley digital health companies rely heavily on armies of faraway coaches
SAN FRANCISCO — Talk to investors about why they like Omada Health, and they point…
STAT Plus: More Americans can’t afford prescriptions and most think Trump isn’t doing enough to help
As President Trump looks toward the next election, a new poll finds that a growing…
Former FDA commissioner calls for a full ban on pod-based e-cigarettes
Former Food and Drug Administration Commissioner Scott Gottlieb is done playing nice on e-cigarettes. He’s…
STAT Plus: Pharmalittle: Biotechs worry about Democrats’ drug pricing bill; PhRMA criticizes four countries over policies
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Meet the 2019 STAT Wunderkinds
Read their stories. Read Original Article: Meet the 2019 STAT Wunderkinds »
Opinion: Should employers take a chance on little-known Embarc to pay for gene therapy?
The promise of curing deadly diseases by administering a one-time therapy that rewrites a patient’s…
It’s tiny biotechs — not big drug makers — that fear ‘nuclear winter’ from Pelosi’s drug pricing bill
WASHINGTON — No one asked Paul Hastings what he thinks about Speaker Nancy Pelosi’s major…
STAT Plus: India’s health care challenges and tech workforce make it fertile ground for AI startups
BENGALURU, India — In September, when Google announced the opening of an artificial intelligence lab…
Google partners with major U.S. health system, gaining access to vast patient data in the process
Google has quietly launched a project with one of the nation’s largest nonprofit health systems…
Cholesterol levels dropping in U.S., but many still need care
WASHINGTON — Some good health news: Americans’ cholesterol levels are dropping, and more people at…
STAT Plus: How much? Pharma copay cards are increasing costs for private Canadian insurers
Amid ongoing criticism of discount cards for prescription medicines, a new study finds these marketing…
Opinion: Confidentiality orders in drug, device lawsuits harm patients and the public
In 2001, West Virginia became the first state to sue Purdue Pharma, the maker of…
Opinion: Diabetic foot ulcers: a silent killer of veterans
Veterans who survive the horrors of war or the other dangers of military service often…
STAT Plus: Long-neglected gene plays a bigger role in Alzheimer’s than suspected, study shows
Just days after news that an ultra-rare form of a cholesterol-related gene called APOE protected…
More than ever before, Democratic presidential hopefuls want to take on pharma. Here’s how they’d do so
The post below is adapted from a STAT Report, “Democrats and drug pricing,” a deeply…
STAT Plus: FDA admits it goofed when granting orphan status to an opioid addiction treatment
In an unusual move, the Food and Drug Administration has acknowledged a mistake and revoked…
STAT Plus: Fibrogen discloses new data that eases heart-safety concerns about experimental anemia pill
Fibrogen presented new clinical trial data on Friday that alleviates concerns about the heart safety…
In a breakthrough, health officials identify possible culprit behind vaping illnesses: vitamin E acetate
Health officials have identified a possible culprit behind the spate of vaping-related illnesses that have…
STAT Plus: Former Biogen sales rep, who says she was fired for complaining about off-label marketing, is awarded $6 million
A federal jury in Seattle has awarded nearly $6 million to a former Biogen (BIIB)…
Top Trump official suggests tobacco regulation distracts from FDA mission
WASHINGTON — President Trump’s domestic policy chief on Friday suggested the regulation of tobacco and…
This booth can virtually connect patients with clinicians and dispense medications. Will patients use it?
TAMPA, Fla. — The bright blue box isn’t big. But squeezed inside it, there’s a…
STAT Plus: A medicinal chemist sees some red flags on China’s newly approved Alzheimer’s drug
Over the weekend, the world got some staggering and perhaps hopeful news. China’s equivalent of…
Sarepta Therapeutics CEO playing nice with FDA over rejection of Duchenne drug
Sarepta Therapeutics CEO Doug Ingram is taking the high road. In remarks Thursday on a…
Listen: An uncertain Alzheimer’s idea, blockbuster fish oil, & a little self-indulgence
Is the latest Alzheimer’s drug for real? Is three a crowd in CAR-T? And what’s…
STAT Plus: Italy is urged not to replace a public health official who pushed for drug pricing transparency
Nearly two dozen health and consumer advocacy groups are urging the Italian health minister not…
STAT Plus: Another former Sun Pharma sales rep claims she was fired for complaining about off-label marketing
A former Sun Pharmaceutical sales employee has a filed a lawsuit claiming retaliation for objecting…
Number of U.S. cases of vaping-related illness tops 2,000
NEW YORK — New government figures show more than 2,000 people have been diagnosed with…
STAT Plus: Startup Arkuda targets rapidly advancing, rare form of dementia
A rare inherited form of early-onset dementia that typically strikes people between the ages of…
STAT Plus: Pharmalittle: HHS sues Gilead over HIV PrEP pill patents; Purdue and Sacklers shielded from lawsuits until April
Top of the morning to you and a fine one it is. Despite gloomy skies…
A Takeda vaccine for dengue appears effective, but the story is nuanced
In the wake of controversy over a Sanofi dengue vaccine, Takeda Pharmaceuticals is betting its…
When it comes to health care, nothing is nonpartisan. Melania Trump’s visit to a Boston hospital harms patients and providers
This morning I was alarmed to learn of first lady Melania Trump’s visit to Boston…
STAT Plus: If Trump were to place tariffs on Swiss drugs, U.S. patients are most likely to get hurt
In the latest bit of saber rattling over trade, the Trump administration last month reportedly…